Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 27256096)

Published in Pediatr Rheumatol Online J on June 02, 2016

Authors

Raphael Leuvenink¹^,2, Florence Aeschlimann³, Walter Baer⁴, Gerald Berthet⁵, Elvira Cannizzaro³, Michael Hofer⁶, Daniela Kaiser⁷, Silke Schroeder³, Ulrich Heininger², Andreas Woerner⁸

Author Affiliations

1: University of Basel Medical School, Basel, Switzerland.
2: Pediatric Rheumatology, University of Basel Children's Hospital, Spitalstrasse 33, CH - 4031, Basel, Switzerland.
3: University Children's Hospital, Zürich, Switzerland.
4: Department of Pediatrics, Hospital of Chur, Chur, Switzerland.
5: Department of Pediatrics, Hospital of Aarau, Aarau, Switzerland.
6: Unité romande de rhumatologie pédiatrique, CHUV, University of Lausanne and HUG, Geneva, Switzerland.
7: Department of Pediatrics, Hospital of Lucerne, Lucerne, Switzerland.
8: Pediatric Rheumatology, University of Basel Children's Hospital, Spitalstrasse 33, CH - 4031, Basel, Switzerland. andreas.woerner@ukbb.ch.

Articles cited by this ↗

Varicella. Lancet (2006) 4.47

Fatal varicella associated with selective natural killer cell deficiency. J Pediatr (2005) 2.60

Varicella in children with cancer: Seventy-seven cases. Pediatrics (1975) 2.29

The epidemiology of varicella and its complications. J Infect Dis (1995) 2.10

Varicella prevention in the United States: a review of successes and challenges. Pediatrics (2008) 1.99

Population-based studies of varicella complications. Pediatrics (1986) 1.90

Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics (2001) 1.67

Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J (2002) 1.63

Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Infect Dis Clin North Am (2010) 1.47

Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics (1993) 1.21

Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr (2005) 1.14

Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis (2013) 1.10

Safety and efficacy of etanercept in a cohort of patients with juvenile idiopathic arthritis under 4 years of age. J Rheumatol (2012) 1.02

Complications of varicella in a defined central European population. Arch Dis Child (1998) 1.01

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum (2013) 0.96

Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine (2011) 0.96

Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis. BMC Pediatr (2011) 0.91

Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine (2001) 0.90

Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J (2001) 0.88

Infections in children treated with biological agents. Pediatr Infect Dis J (2013) 0.82

Incidence of herpes zoster infections in juvenile idiopathic arthritis patients. Rheumatol Int (2015) 0.77